ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiac failure Vol. 25; no. 11; pp. 854 - 865
Main Authors Dorbala, Sharmila, Ando, Yukio, Bokhari, Sabahat, Dispenzieri, Angela, Falk, Rodney H., Ferrari, Victor A., Fontana, Marianna, Gheysens, Olivier, Gillmore, Julian D., Glaudemans, Andor W.J.M., Hanna, Mazen A., Hazenberg, Bouke P.C., Kristen, Arnt V., Kwong, Raymond Y., Maurer, Mathew S., Merlini, Giampaolo, Miller, Edward J., Moon, James C., Murthy, Venkatesh L., Quarta, C.Cristina, Rapezzi, Claudio, Ruberg, Frederick L., Shah, Sanjiv J., Slart, Riemer H.J.A., Verberne, Hein J., Bourque, Jamieson M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.
ISSN:1071-9164
1532-8414
DOI:10.1016/j.cardfail.2019.08.002